Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
545.5 SEK | -0.46% | -1.71% | +1.39% |
05-23 | Camurus' Rare Growth Disorder Drug Accepted for Review in EU | MT |
05-23 | Camurus Receives EMA Acceptance of MAA Filing for Octreotide SC Depot for the Treatment of Acromegaly | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.39% | 2.98B | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.47% | 238B | |
+7.35% | 204B | |
-6.42% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- CAMX Stock
- News Camurus AB
- Camurus' : CFO Steps Down